AKT1 and esophageal squamous cell carcinoma: Liu et al. demonstrated that lncRNA FOXD2-AS1 acts as a competitive endogenous RNA targeting miR-195, promoting ESCC cell growth by activating the AKT/mTOR signaling pathway, inhibiting apoptosis, and developing DDP resistance (Liu et al., 2020b).